Sugi Predict

Sugi Predict / Compounds / SCHEMBL44144

SCHEMBL44144

SCHEMBL44144

O=C1C=CC(=O)N1CCN(CCN1C(=O)C=CC1=O)CCN1C(=O)C=CC1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 11/20 0.59
▸ FAAH O00519 5/20 0.59
▸ ALDH1A1 P00352 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.56
▸ HSP90AA1 P07900 1/20 0.56
▸ TLR9 Q9NR96 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ XBP1 P17861 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ GPR35 Q9HC97 1/20 0.56
▸ GPR55 Q9Y2T6 1/20 0.56
▸ PTGS1 P23219 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1535392 0.97 MGLL (0.56) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL15298752 0.89 MGLL (0.53) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL6534991 0.89 MGLL (0.48) MGLLFAAHALDH1A1LMNAMAPT
Acetic Acid SCHEMBL1827504 0.87 PTGS1 (0.47) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL13213415 0.87 MGLL (0.46) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL11053925 0.86 MGLL (0.50) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL17453110 0.82 PTGS1 (0.43) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL20153840 0.82 PTGS1 (0.43) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL21777709 0.81 PTGS1 (0.50) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL7537932 0.81 MGLL (0.50) MGLLFAAHALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011398-A Polyurethane foam homogenizing agent and preparation method thereof 安徽麦宸科技有限公司 2026-05-12 — — CN claimed
US-12472267-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2025-11-18 — — US claimed
US-20250295745-A1 CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES NORTHWESTERN UNIVERSITY 2025-09-25 — — US claimed
CN-119859324-A Odor-free asphalt additive, odor-free asphalt and preparation method thereof 中国石油化工股份有限公司 2025-04-22 — — CN claimed
CN-119264155-A Latent curing agent based on dynamic crosslinking-controllable dissolution mechanism 江南大学 2025-01-07 — — CN claimed
CN-118994872-A Multifunctional thermal reversible 3D printing material and preparation method thereof 中山大学 2024-11-22 — — CN claimed
CN-117757053-B Multi-branched polycaprolactone and preparation method thereof 湖南聚仁新材料股份公司 2024-10-15 — — CN claimed
CN-118359753-A Self-repairing polymer resin material and self-repairing ink containing same 株式会社日立产机系统 2024-07-19 — — CN claimed
CN-118256468-A Modified ToPif1 helicase and application thereof 北京普译生物科技有限公司 2024-06-28 — — CN claimed
CN-117965034-A Odor-free asphalt additive, odor-free asphalt and preparation method thereof 中国石油化工股份有限公司 2024-05-03 — — CN claimed
WO-2011053940-A2 TEMPLATED NANOCONJUGATES NORTHWESTERN UNIVERSITY (US) 2011-05-05 — — WO claimed
CN-102008732-A Folate conjugated antibody drug, and preparation method and application thereof CHINA LONGEVOVS MEDICINES HUBEI CO LTD 2011-04-13 — — CN claimed
WO-2010063725-A2 STRUCTURING PARTICLES INTO USEFUL STRUCTURES AND THEIR USE IN LIFE SCIENCE MATTIASSON BO (SE) 2010-06-10 — — WO claimed
US-20100022699-A1 RUBBER COMPOSITION CONTAINING A POLYMALEIMIDE COMPOUND MICHELIN RECHERCHE ET TECHNIQUE S.A. (CH) 2010-01-28 — — US claimed
US-7604804-B2 Two gp120 binding molecules that target the CD4 binding pocket on a trimeric HIV gp120 complex and gp120 binding molecules are separated by a spacer/linker of sufficient length to provide for binding of the gp120 binding molecules to the CD-4 binding sites on trimeric gp120 sites on virion surface UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2009-10-20 — — US claimed
EP-2104707-A1 RUBBER COMPOSITION CONTAINING A POLYMALEIMIDE COMPOUND Société de Technologie MICHELIN (FR) 2009-09-30 — — EP claimed
WO-2008080553-A1 RUBBER COMPOSITION CONTAINING A POLYMALEIMIDE COMPOUND SOCIETE DE TECHNOLOGIE MICHELIN (FR) 2008-07-10 — — WO claimed
US-20050176642-A1 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 UNIVERSITY OF MARYLAND, BALTIMORE 2005-08-11 — — US claimed
EP-0665853-A1 MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS Diatide, Inc. (US) 1995-08-09 — — EP claimed
WO-1994007918-A1 MULTIMERIC POLYVALENT ANTITHROMBOTIC AGENTS DIATECH, INC. (US) 1994-04-14 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176642-A1 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 CD4, CD40LG, NECTIN4 MGLL 2728/4885FAAH 4698/4885ALDH1A1 4795/4885
US-12472267-B2 Compositions containing nucleic acid nanoparticles with modular functionality NCL, NSUN3, POLN MGLL 4186/4885FAAH 4212/4885ALDH1A1 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.